Get the Stockscreener App
29.11
1.93%
0.55
Liquidia Corp stock is traded at $29.11, with a volume of 2.17M.
It is up +1.93% in the last 24 hours and up +23.40% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$28.56
Open:
$28.06
24h Volume:
2.17M
Relative Volume:
0.86
Market Cap:
$2.53B
Revenue:
$19.32M
Net Income/Loss:
$-141.47M
P/E Ratio:
-17.27
EPS:
-1.6851
Net Cash Flow:
$-120.48M
1W Performance:
+3.82%
1M Performance:
+23.40%
6M Performance:
+74.73%
1Y Performance:
+186.80%
1-Day Range:
$27.76
$29.51
1-Week Range:
$27.67
$30.88
52-Week Range:
$10.02
$30.88
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Industry
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
29.11 | 2.48B | 19.32M | -141.47M | -120.48M | -1.6851 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-15-25 | Resumed | Jefferies | Buy |
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
A Fresh Look at Liquidia (LQDA) Valuation Following Recent Share Price Surge - Yahoo Finance UK
Liquidia Corp's Chief Business Officer Sells Shares - TradingView
[Form 4] Liquidia Corp Insider Trading Activity - Stock Titan
Meridian Wealth Management LLC Takes $168,000 Position in Liquidia Corporation $LQDA - MarketBeat
What sentiment indicators say about Liquidia Corporation stockJuly 2025 Trends & Safe Entry Zone Tips - newser.com
Why Liquidia Corporation (LT4) stock fits value portfolios2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
How Liquidia Corporation (LT4) stock reacts to new regulationsWall Street Watch & Technical Entry and Exit Alerts - newser.com
Will Liquidia Corporation (LT4) stock outperform small cap peersJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - newser.com
Healthcare’s Momentum Gathers Steam. 3 Stocks With Bullish Charts. - Barron's
Liquidia (NASDAQ:LQDA) Hits New 52-Week HighHere's Why - MarketBeat
Liquidia Corporation $LQDA Stock Position Cut by Patient Square Capital LP - MarketBeat
Why Liquidia Corporation stock is a value investor pickJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com
Published on: 2025-11-19 05:01:37 - newser.com
Why Liquidia Corporation (LT4) stock is trending on social mediaEarnings Beat & Stock Portfolio Risk Control - newser.com
Can Liquidia Corporation (LT4) stock test all time highsJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - newser.com
Liquidia Technologies stock hits 52-week high of 29.97 USD By Investing.com - Investing.com South Africa
Liquidia Technologies stock hits 52-week high of 29.97 USD - Investing.com
Liquidia at Jefferies: Strategic Growth and Legal Challenges - Investing.com
Published on: 2025-11-18 05:06:23 - newser.com
Will Liquidia Corporation (LT4) stock beat value stocksTrade Analysis Summary & Long-Term Capital Growth Strategies - newser.com
Published on: 2025-11-17 15:03:22 - newser.com
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch - AOL.com
Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Liquidia Corporation $LQDA - MarketBeat
Published on: 2025-11-17 12:10:02 - newser.com
Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA's 75% Growth in U.S. Prostacyclin Revenue - Finviz
Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA’s 75% Growth in U.S. Prostacyclin Revenue - Insider Monkey
Mitsubishi UFJ Asset Management Co. Ltd. Sells 108,494 Shares of Liquidia Corporation $LQDA - MarketBeat
Liquidia Stock: Biotech Firm Delivers Stellar Performance - AD HOC NEWS
Chart overlay techniques for tracking Liquidia CorporationGDP Growth & Safe Capital Growth Plans - newser.com
How to escape a deep drawdown in Liquidia CorporationJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Tyro Capital Management LLC Takes $15.47 Million Position in Liquidia Corporation $LQDA - MarketBeat
Can Liquidia Corporation (LT4) stock sustain double digit ROEQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Liquidia Corp's Chief Accounting Officer Sells Shares - TradingView
Published on: 2025-11-12 09:23:46 - newser.com
Liquidia at UBS Global Healthcare: Strategic Growth in Focus - Investing.com
Will Liquidia Corporation stock benefit from automation2025 Market Trends & Weekly Watchlist for Hot Stocks - newser.com
Liquidia Shares Surge on Exceptional Quarterly Performance - AD HOC NEWS
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):